Abstract
BackgroundThe COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has instigated immediate and massive worldwide research efforts. Rapid publication of research data may be desirable but also carries the risk of quality loss.ObjectiveThis analysis aimed to correlate the severity of the COVID-19 outbreak with its related scientific output per country.MethodsAll articles related to the COVID-19 pandemic were retrieved from Web of Science and analyzed using the web application SciPE (science performance evaluation), allowing for large data scientometric analyses of the global geographical distribution of scientific output.ResultsA total of 7185 publications, including 2592 articles, 2091 editorial materials, 2528 early access papers, 1479 letters, 633 reviews, and other contributions were extracted. The top 3 countries involved in COVID-19 research were the United States, China, and Italy. The confirmed COVID-19 cases or deaths per region correlated with scientific research output. The United States was most active in terms of collaborative efforts, sharing a significant amount of manuscript authorships with the United Kingdom, China, and Italy. The United States was China’s most frequent collaborative partner, followed by the United Kingdom.ConclusionsThe COVID-19 research landscape is rapidly developing and is driven by countries with a generally strong prepandemic research output but is also significantly affected by countries with a high prevalence of COVID-19 cases. Our findings indicate that the United States is leading international collaborative efforts.
Highlights
The global pandemic caused by the novel coronavirus SARS-CoV-2, leading to the disease COVID-19, has instigated immediate and massive worldwide research activities
We refrained from adding the word “corona” to our search term, as this may identify publications unrelated to the COVID-19 pandemic
In the initial search on July 4, 2020, a total of 7185 publications were extracted from Web of Science Core Collection (WoS), including 2592 articles, 2091 editorial materials, 2528 early access papers, 1479 letters, 633 reviews, and other contributions (Figure 1)
Summary
The global pandemic caused by the novel coronavirus SARS-CoV-2, leading to the disease COVID-19, has instigated immediate and massive worldwide research activities. Literature on preprint servers is increasing enormously Prominent servers such as bioRxiv and medRxiv receive numerous new manuscripts each day and currently list 6063 articles (as of July 4, 2020). Peer-reviewed literature is growing at an unprecedented rate with articles published in various leading medical and related journals [1,2,3]. Some manuscripts have been accepted on the day of submission, which calls into question the completion of a sufficient peer-review process [4], leading to a relatively high number of retractions even in high-ranking journals [5,6]. The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has instigated immediate and massive worldwide research efforts. Rapid publication of research data may be desirable and carries the risk of quality loss
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
